Ad Header

PharmaLive

Slogan

The Pulse of the Pharmaceutical Industry

  • Filter By Category

  • Filter By Author

AstraZeneca science is on the move, one year on from Pfizer bid

(Reuters) – Having seen off a hostile $118 billion bid launched a year ago by U.S. rival Pfizer, Anglo-Swedish company AstraZeneca is on the move — quite literally.  As of last month, a four-days-a-week service set up by the drugmaker with Sun Air is connecting staff in its new Cambridge science and operations hub with […]

Read More »

Veeva Systems Introduces Global Key Opinion Leader (KOL) Data and Services Solution

New KOL solution – based upon newly acquired Qforma CrowdLink business – to help life sciences companies drive more successful product launches  PLEASANTON, CA and MORRISTOWN, NJ – April 15, 2015 – Veeva Systems (NYSE: VEEV) kicked off the ExL Pharma Medical Affairs Strategic Summit today unveiling Veeva KOL Data & Services, a new solution […]

Read More »

GlaxoSmithKline seeks injunction preventing roll-out by rival of inhaler

The Irish Times Tue, Apr 14, 2015, 17:19 A major pharmaceutical company has claimed alleged infringement of its trademark entitles it to an injunction preventing the roll-out by a rival of an inhaler for asthmatics. GlaxoSmithKline (GSK) says Rowex Ltd is preparing to put on the market a product similar in its packaging to Glaxo’s “Seretide” […]

Read More »

21st Century Cures discussion draft includes textbook/reprint language, communication fixes

By John Kamp New legislation to spur medical innovation through new authorities for FDA and NIH is creating a lot of buzz in the Washington medical community, most of it very good. Indeed, even with outgoing FDA Commissioner Margaret Hamburg’s March 30 note of caution that regulatory innovation requires increased staff and other resources, the passage […]

Read More »

Should The FDA Require CV Outcome Studies For Diabetes Drugs Before Approval?

As the waistline of Americans has increased, so has the incidence of Type 2 diabetes. Startling data from the Centers for Disease Control  shows that that prevalence of this disease, which is directly related to obesity, now exceeds 9% in the adult population. It was less than half that rate in 1996. Furthermore, there doesn’t […]

Read More »

Diabetes Drugs Get Neither Restrictions Nor Endorsements From FDA Committee

Two diabetes drugs survived a meeting of the FDA’s Endocrinologic and Metabolic Drugs Advisory Committee on Tuesday. Rejecting recommendations from critics that the drugs should either be withdrawn or get new restrictions on use, the committee voted against any harsh measures, recommending only that information from two neutral clinical  trials with the drugs be added to the drugs’ labels. […]

Read More »

PerkinElmer Launches First Fully Automated Genetic Disorder Screening System in China

WALTHAM, Mass. & SHANGHAI–(BUSINESS WIRE)–PerkinElmer, Inc., a global leader focused on improving the health and safety of people and the environment, today announced that it has received market authorization from the China Food and Drug Administration (CFDA) to offer its Genetic Screening Processor® (GSP) instrument and GSP Neonatal hTSH reagent kit. The GSP is a […]

Read More »

FDA panel backs safety updates for AstraZeneca, Takeda drugs

A sign is seen at an AstraZeneca site in Macclesfield, central England May 19, 2014. Reuters/Phil Noble (Reuters) – AstraZeneca Plc’s diabetes drug Onglyza and Takeda Pharmaceutical Co.’s rival product Nesina should carry information about the risk of heart failure, an advisory committee to the U.S. Food and Drug Administration said on Tuesday.   Heart […]

Read More »

U.S. Solicitor General Intervenes Against Johnson & Johnson in DECN’s Long Running Patent Battle Over GenStrip 50

Interventions by the Solicitor’s Office to Protect the Rights of a Corporation Are Rare LOS ANGELES, CA–(Marketwired – Apr 14, 2015) – Decision Diagnostics Corp. (OTC PINK: DECN), the manufacturer, quality plan administrator and the exclusive worldwide sales, service and regulatory processes agent for the popular GenStrip™ 50, the FDA cleared Green Alternative Strip, specifically […]

Read More »

Healthcare ad agency recruiting 101: A Q&A with Matthew West

Matthew West spent 14 years at McCann RCW as VP/chief talent officer; now West is a director of AdvicePersonnel, a boutique recruitment company, where he specializes in finding talent for healthcare advertisingagencies. In an industry where every agency president says good talent is difficult to find, West has someinsights about where to find it and […]

Read More »

Ad Right Top

MedAdNews

Extensive pharmaceutical business and marketing intelligence. For back issues, please contact MDAD@kmpsgroup.com.

February 2019 Focus: Agenda 2019, Top 10 Pipelines To Watch, Value Of Pharmaceuticals, and more!

Subscribe

Ad Right Bottom